Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment. | Front Pharmacol | 2022 | 35273499 | PubTator, text mining | PubMed |
| Deep Learning-Based Pan-Cancer Classification Model Reveals Tissue-of-Origin Specific Gene Expression Signatures. | Cancers (Basel) | 2022 | 35267493 | PubTator, text mining | PubMed |
| The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes. | BMC Res Notes | 2022 | 35246243 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS). | Eur J Med Chem | 2022 | 35219151 | PubTator, text mining | PubMed |
| SWAAT Bioinformatics Workflow for Protein Structure-Based Annotation of ADME Gene Variants. | J Pers Med | 2022 | 35207751 | PubTator, text mining | PubMed |
| Arylalkalamine N-acetyltransferase-1 acts on a secondary amine in the yellow fever mosquito, Aedes aegypti. | FEBS Lett | 2022 | 35178730 | PubTator, text mining | PubMed |
| Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population. | PLoS One | 2022 | 35176049 | PubTator, text mining | PubMed |
| Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. | Nat Commun | 2022 | 35173148 | PubTator, text mining | PubMed |
| Phosphorylation of Eukaryotic Initiation Factor 4G1 (eIF4G1) at Ser1147 Is Specific for eIF4G1 Bound to eIF4E in Delayed Neuronal Death after Ischemia. | Int J Mol Sci | 2022 | 35163752 | PubTator, text mining | PubMed |
| An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. | Int J Mol Sci | 2022 | 35163157 | PubTator, text mining | PubMed |
| Epigenetic Therapies and Biomarkers in Breast Cancer. | Cancers (Basel) | 2022 | 35158742 | PubTator, text mining | PubMed |
| Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status. | Front Pharmacol | 2022 | 35153780 | PubTator, text mining | PubMed |
| Local anesthetics for the Nephrologist. | Clin Kidney J | 2022 | 35145634 | PubTator, text mining | PubMed |
| Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis. | Mol Carcinog | 2022 | 35133049 | PubTator, text mining | PubMed |
| Diagnostic Performance of an App-Based Symptom Checker in Mental Disorders: Comparative Study in Psychotherapy Outpatients. | JMIR Ment Health | 2022 | 35099395 | PubTator, text mining | PubMed |
| Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease. | J Endocr Soc | 2022 | 35059548 | PubTator, text mining | PubMed |
| In Vitro Evaluation of the Cytotoxic Effect of Streptococcus pyogenes Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line. | Molecules | 2022 | 35056889 | PubTator, text mining | PubMed |
| Ribosomal leaky scanning through a translated uORF requires eIF4G2. | Nucleic Acids Res | 2022 | 35018467 | PubTator, text mining | PubMed |
| Dill Shows Potential for Herb-Drug Interactions via Up-Regulation of CYP1A2, CYP2C19, SULT1A1, NAT2 and ABCB1 in Caco-2 Cells. | Pak J Biol Sci | 2022 | 35001576 | PubTator, text mining | PubMed |
| Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial. | Clin Breast Cancer | 2022 | 34980541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=12